See All Slides - tctmd.com

Slides

Presentation TCT 2015

Cardiogenic Shock and Hemodynamic Support

Presenter: Manish A. Parikh, Sahil A. Parikh

October 12, 2015

Presentation TCT 2015

DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)

Presenter: Spencer B. King III, Jagat Narula, James B. Hermiller Jr

October 12, 2015

Presentation TCT 2015

CoreValve US Extreme Risk: Evaluation of a Self-Expanding Transcatheter Aortic Valve in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery

Presenter: Spencer B. King III, Jagat Narula, James B. Hermiller Jr

October 12, 2015

Presentation TCT 2015

OPEN CTO: Evaluation of a Hybrid Approach to Chronic Total Occlusion Coronary Intervention

Presenter: Spencer B. King III, Jagat Narula, J. Aaron Grantham

October 12, 2015

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Presenter: Dean J. Kereiakes, Ron Waksman, Davide Capodanno, Michael Haude

October 12, 2015

Presentation TCT 2015

Intravascular Imaging: IVUS, OCT, and NIRS

Presenter: John McB. Hodgson, Allen Jeremias

October 12, 2015

Presentation TCT 2015

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Presenter: Shigeru Saito, Gregg W. Stone, Ron Waksman, Shigeru Saito

October 12, 2015

Presentation TCT 2015

Percutaneous Aortic Valve Repair Technologies 4: The V8 BAV Technology Description and Clinical Results

Presenter: Alain G. Cribier, Eberhard Grube, Wesley R. Pedersen

October 12, 2015

Presentation TCT 2015

Percutaneous Aortic Valve Repair Technologies 3: Aortic Leaflet Restoration Using Balloon-Based Lithoplasty

Presenter: Alain G. Cribier, Eberhard Grube, Todd J. Brinton

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Advertisement

Slides

Cardiogenic Shock and Hemodynamic Support

DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)

CoreValve US Extreme Risk: Evaluation of a Self-Expanding Transcatheter Aortic Valve in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery

OPEN CTO: Evaluation of a Hybrid Approach to Chronic Total Occlusion Coronary Intervention

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Intravascular Imaging: IVUS, OCT, and NIRS

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Percutaneous Aortic Valve Repair Technologies 4: The V8 BAV Technology Description and Clinical Results

Percutaneous Aortic Valve Repair Technologies 3: Aortic Leaflet Restoration Using Balloon-Based Lithoplasty

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content